Patient-Reported Outcomes in Patients with T2D and increased CV risk on Tirzepatide or Insulin Glargine (SURPASS-4)
Keyword(s):
2014 ◽
Vol 16
(11)
◽
pp. 1121-1127
◽
Keyword(s):
2019 ◽
Vol 35
(9)
◽
pp. 1623-1629
◽
2008 ◽
Vol 10
(s2)
◽
pp. 50-65
◽
Keyword(s):
2012 ◽
Vol 36
(5)
◽
pp. S41
◽
Keyword(s):
2017 ◽
Vol 39
(11)
◽
pp. 2284-2295
◽